Changyu Pharmaceutical

Zhejiang Changyu Pharmaceutical is a specialized Chinese pharmaceutical company focused on the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced chemical intermediates. The company is a prominent global supplier in the central nervous system (CNS) therapeutic area, particularly known for its high-volume manufacturing of Gabapentin and Pregabalin. Operating from GMP-certified facilities in Zhejiang province, Changyu serves both domestic and international markets, maintaining rigorous quality standards for regulated pharmaceutical environments. In addition to its CNS portfolio, the company produces treatments for metabolic disorders and cardiovascular diseases, while also offering contract manufacturing (CMO) services for custom synthesis. Their business model integrates chemical synthesis expertise with industrial-scale production to support global generic and innovative drug supply chains.